X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

SkyCell and AirBridgeCargo expand partnership for passive pharma solutions services in airfreight

Content Team by Content Team
20th June 2019
in Packaging & Logistic, Press Statements
SkyCell passive pharma solutions

AirBridgeCargo Airlines (ABC) and SkyCell have sealed a close partnership for the lease of all types of SkyCell’s temperaturecontrolled containers. Russian all-cargo airline ABC is one of the global leaders in transportation of pharmaceutical products by air. With its innovative container solutions, Swiss-based SkyCell has become one of the most successful manufacturer and service providers of temperature-controlled containers for pharmaceuticals. With their close partnership, both companies want to meet the rising demand in pharmaceutical shipments. At ABC, the global volume for such high-value shipments doubled in Q1 2019 to around 3,500 tons.

“With SkyCell containers we have increased the total number of cold-chain special packaging solutions partners aiming at embracing all leading manufacturers to cater to the needs of different customers. SkyCell data-collection enablement supports our intention to move further with ‘Internet of Things’ penetration into the industry and step aside from peer-to-peer data sharing to information transparency and availability. On top of this, it fosters an extra piece of mind for our customers to have real-time data in one click,” said Fedor Novikov, Deputy General Director, Products, AirBridgeCargo Airlines.

The SkyCell line of passive containers is capable of keeping the internal temperature within the range of +2° to +8°C and +15°C to +25°C under external temperature excursions from – 35°C to +65°C to meet the requirements of various pharmaceutical manufacturers, as well as logistics companies involved in a complex transportation process. With its award-winning and quality audited performance of its temperature-controlled pharma containers, SkyCell is constantly pushing for innovation and better services. For every shipment, SkyCell experts use the SkyCell Transport Planner for risk assessment and define lane SOPs together with the shipper, freight forwarder and airlines, producing a comprehensive lane risk analysis “ABC has one of the most modern airline fleets and, like SkyCell, is committed to greater transparency in the industry. Together we strive to make pharmaceutical logistics safer, more reliable and more sustainable,” said Richard Ettl, CEO of SkyCell.

AirBridgeCargo has adopted a thorough and well-balanced approach towards the development of its dedicated ‘ABC pharma’ product. It is continuously reinforcing its team of experts, expanding its pool of special packaging manufacturers and implementing the latest digital solutions. Most importantly, it is constantly deepening its field-specific knowledge and sharing it with customers and partners through educational workshops and aircraft tours.

About SkyCell:
SkyCell is a leading airfreight container provider with the mission to supply the safest pharma containers worldwide. This is achieved through the unique combination of hardware, software and service, enabling our clients to master logistical challenges and eliminate temperature excursion.

Pharma companies have tested and verified SkyCell as the safest solution on the market, with less than 0.1% temperature deviations since launch. The efficient insulation and cutting-edge cooling technology enable the containers to keep the temperature for 160h+. All containers are equipped with IoT sensors, leading to a seamless supply chain through global tracking and monitoring. Based in Switzerland and with a global service station network, SkyCell is serving pharma companies around the world.
For more information visit www.skycell.ch

 

About AirBridgeCargo Airlines

AirBridgeCargo is one of the global cargo carriers with an expanded international route network which connects customers in the largest trans-regional markets of Asia, Europe, and North America and covers more than 30 major cargo gateways, accommodating trade flows worldwide. All the flights are operated via ABC’s cargo hub in Moscow Sheremetyevo airport, featuring up-to-date equipment and guaranteeing seamless connection throughout the airline’s expanded international network within a 48-hour delivery time, including handling, all managed by highly skilled and qualified ground handling personnel. ABC’s fleet consists of 18 Boeing 747 freighters and is one of the youngest and most modern in the airline industry.

More information: www.airbridgecargo.com

 

Previous Post

DHL invests $150M to expand pharma, medical supply chain

Next Post

IBM KPMG Merck and Walmart to collaborate as part of FDA s program to evaluate the use of blockchain to protect pharmaceutical product integrity

Related Posts

ACHEMA 2022 addresses the industry's key issues digitalisation and sustainability
Manufacturing

ACHEMA 2022 addresses the industry’s key issues digitalisation and sustainability

14th June 2022
development of new antibiotics
Drug Development

EMA guidance supports development of new antibiotics

30th May 2022
Vienna Airport and Lufthansa Cargo launch pharma cooperation
Packaging & Logistic

Vienna Airport and Lufthansa Cargo launch pharma cooperation

10th May 2022
Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities
Drug Development

Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

6th May 2022
Catalent Expands Nasal Drug Development and Manufacturing Capabilities at Morrisville, North Carolina, Facility
Press Statements

Catalent Expands Nasal Drug Development and Manufacturing Capabilities at Morrisville, North Carolina, Facility

6th May 2022
AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint
Drug Development

AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

6th May 2022
Next Post
blockchain to protect pharmaceutical product integrity

IBM KPMG Merck and Walmart to collaborate as part of FDA s program to evaluate the use of blockchain to protect pharmaceutical product integrity

Latest News

Dupixent From Sanofi Delivers Another Fantastic Performance
Manufacturing

Sanofi Sets Up Fund To Enable Firms In Low-Income Countries

5th July 2022
GSK commences phase III study of Benlysta and rituximab combination in systemic lupus erythematosus
Manufacturing

Singapore Authorises New Ovarian Cancer Treatment By GSK

5th July 2022
Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
Manufacturing

Abbott India Affirms That The Medicines Are Not Their Own

5th July 2022
Global Biopharmaceutical Bioseparation Market Eyeing $20bn
Manufacturing

Global Biopharmaceutical Bioseparation Market Eyeing $20bn

4th July 2022
FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters
Manufacturing

FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters

4th July 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In